High relaxivity Gd-based organic nanoparticles for efficient magnetic resonance angiography.

Journal: Journal of nanobiotechnology
Published Date:

Abstract

Contrast-enhanced MR angiography (MRA) is a critical technique for vascular imaging. Nevertheless, the efficacy of MRA is often limited by the low rate of relaxation, short blood-circulation time, and metal ion-released potential long-term toxicity of clinical available Gd-based contrast agents. In this work, we report a facile and efficient strategy to achieve Gd-chelated organic nanoparticles with high relaxivity for T-weighted MRA imaging. The Gd-chelated PEG-TCPP nanoparticles (GPT NPs) have been engineered composite structured consisting of Gd-chelated TCPP and PEG. The spherical structure of TCPP offers more chemical sites for Gd coordination to improve the relaxivity and avoid leakage of the Gd ions. The synthesized GPT NPs exhibit a high relaxation rate of 35.76 mM s at 3.0 T, which is higher than the rates for most reported MR contrast agents. Therefore, GPT NPs can be used for MRA with much stronger vascular signals, longer circulation time, and high-resolution arterial vascular visualization than those using clinical MR contrast agents at the same dose. This work may make the T MRI contrast agents for high-resolution angiography possible and offer a new candidate for preclinical and clinical applications of MR vascular imaging and vascular disease diagnosis.

Authors

  • Zhuang Liu
    Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Menglong Zhao
    Department of Intensive Care Unit, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, Anhui, China.
  • Han Wang
    Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, Singapore.
  • Zi Fu
    Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Hongbo Gao
    Department of Radiation Oncology, Huadong Hospital Affiliated to Fudan University, Shanghai, 200040, China.
  • Weijun Peng
    Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Dalong Ni
    Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. ndl12353@rjh.com.cn.
  • Wei Tang
    Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yajia Gu
    Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. cjr.guyajia@vip.163.com.